MiR-548-3p functions as an anti-oncogenic regulator in breast cancer

被引:64
|
作者
Shi, Yafei [1 ]
Qiu, Min [1 ]
Wu, Yanyan [1 ]
Hai, Lu [2 ]
机构
[1] Affiliated Hosp Jining Med Univ, Dept Breast & Thyroid Surg, Jining City, Shandong, Peoples R China
[2] Jining Med Univ, Jining City, Shandong, Peoples R China
关键词
Breast cancer; MicroRNAs; MiR-548-3p; ECHS1;
D O I
10.1016/j.biopha.2015.07.027
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Emerging evidence has found that microRNAs (miRNA) play an important role in breast cancer. MiR-548 family has been demonstrated to be involved in the pathogenesis of several cancers. However, its role in breast cancer has not yet been elucidated. To explore this concern, we explored the expression of miR-548- 3p in clinical specimens and breast cancer cells by qRT-PCR. In addition, an CCK-8 assay and Caspase 3/7 activity were used to evaluated the rates of cell proliferation and apoptosis. Protein expression was analyzed by western blotting and the target gene was confirmed using a luciferase reporter assay. Our results illustrated that miR-548-3p was significantly downregulated in breast cancer. Overexpression of miR-548-3p inhibited the proliferation and promoted the apoptosis of breast cancer cells. In addition, ECHS1 expression was demonstrated to be significantly upregulated in breast cancer tissues and cells, and the ECHS1 gene was identified to be one target of miR-548-3p. Therefore, our results demonstrated that miR-548-3p inhibited the proliferation of breast cancer cells by regulating the expression of ECHS1, indicating its potential as a therapeutic target for breast cancer. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:111 / 116
页数:6
相关论文
共 50 条
  • [41] mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK
    Liu, Peng
    Ye, Feng
    Xie, Xinhua
    Li, Xing
    Tang, Hailin
    Li, Shuaijie
    Huang, Xiaojia
    Song, Cailu
    Wei, Weidong
    Xie, Xiaoming
    ONCOTARGET, 2016, 7 (23) : 35188 - 35198
  • [42] Retinoids and EZH2 inhibitors cooperate to orchestrate anti-oncogenic effects on bladder cancer cells
    Ozgun, Gizem
    Yaras, Tutku
    Akman, Burcu
    Ozden-Yilmaz, Guelden
    Landman, Nick
    Karakulah, Gokhan
    van Lohuizen, Maarten
    Senturk, Serif
    Erkek-Ozhan, Serap
    CANCER GENE THERAPY, 2024, 31 (04) : 537 - 551
  • [43] Retinoids and EZH2 inhibitors cooperate to orchestrate anti-oncogenic effects on bladder cancer cells
    Gizem Ozgun
    Tutku Yaras
    Burcu Akman
    Gülden Özden-Yılmaz
    Nick Landman
    Gökhan Karakülah
    Maarten van Lohuizen
    Serif Senturk
    Serap Erkek-Ozhan
    Cancer Gene Therapy, 2024, 31 : 537 - 551
  • [44] Comprehensive identification of microRNA arm selection preference in lung cancer: miR-324-5p and-3p serve oncogenic functions in lung cancer
    Lin, Min-Hsi
    Chen, You-Zuo
    Lee, Mei-Yu
    Weng, Ken-Pen
    Chang, Hong-Tai
    Yu, Shou-Yu
    Dong, Bo-Jhu
    Kuo, Fan-Rong
    Hung, Li-Tzu
    Liu, Li-Feng
    Chen, Wei-Shone
    Tsai, Kuo-Wang
    ONCOLOGY LETTERS, 2018, 15 (06) : 9818 - 9826
  • [45] miR-548 predicts clinical prognosis and functions as a tumor promoter in gastric cancer
    Chen, Guoyan
    Shang, Jingjuan
    Li, Minhong
    Zhang, Huijun
    Xu, Hui
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (05) : 1633 - 1639
  • [46] miR-548 predicts clinical prognosis and functions as a tumor promoter in gastric cancer
    Guoyan Chen
    Jingjuan Shang
    Minhong Li
    Huijun Zhang
    Hui Xu
    Clinical and Experimental Medicine, 2023, 23 : 1633 - 1639
  • [47] Anti-Oncogenic gem-Dihydroperoxides Induce Apoptosis in Cancer Cells by Trapping Reactive Oxygen Species
    Kuranaga, Yuki
    Yamada, Nami
    Kashiwaya, Maiko
    Nakamura, Moeko
    Cui, Lei
    Kumazaki, Minami
    Shinohara, Haruka
    Sugito, Nobuhiko
    Taniguchi, Kohei
    Ito, Yuko
    Nakayama, Tatsushi
    Uno, Bunji
    Itoh, Akichika
    Akao, Yukihiro
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (01)
  • [48] CLK2 Is an Oncogenic Kinase and Splicing Regulator in Breast Cancer
    Yoshida, Taku
    Kim, Jee Hyun
    Carver, Kristopher
    Su, Ying
    Weremowicz, Stanislawa
    Mulvey, Laura
    Yamamoto, Shoji
    Brennan, Cameron
    Mei, Shenglin
    Long, Henry
    Yao, Jun
    Polyak, Kornelia
    CANCER RESEARCH, 2015, 75 (07) : 1516 - 1526
  • [49] Oncogenic potential of TSTA3 in breast cancer and its regulation by the tumor suppressors miR-125a-5p and miR-125b
    Sun, Yanan
    Liu, Xiaohong
    Zhang, Qingfu
    Mao, Xiaoyun
    Feng, Liang
    Su, Peng
    Chen, Hao
    Guo, Yang
    Jin, Feng
    TUMOR BIOLOGY, 2016, 37 (04) : 4963 - 4972
  • [50] Berbamine Exerts an Anti-oncogenic Effect on Pancreatic Cancer by Regulating Wnt and DNA Damage-related Pathways
    Hu, Bingren
    Yang, Yingnan
    Tu, Jinfu
    Cai, Huajie
    Yang, Shouzhang
    Chen, Xinwei
    Chen, Gang
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (02) : 201 - 209